Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Nanjing Medical UniversityNo recent work listed

Keming Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1358-3562; OpenAlex author ID A5088932131. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 2 papers

Papers 4

  1. RREB1-induced upregulation of the lncRNA AGAP2-AS1 regulates the proliferation and migration of pancreatic cancer partly through suppressing ANKRD1 and ANGPTL4. Co-author DOI 10.1038/s41419-019-1384-9↗
  2. Overexpressed long noncoding RNA TUG1 affects the cell cycle, proliferation, and apoptosis of pancreatic cancer partly through suppressing RND3 and MT2A. Co-author DOI 10.2147/ott.s188396↗
  3. Long non-coding RNA SNHG15 inhibits P15 and KLF2 expression to promote pancreatic cancer proliferation through EZH2-mediated H3K27me3. Last author DOI 10.18632/oncotarget.20359↗
  4. Long non-coding RNA IRAIN suppresses apoptosis and promotes proliferation by binding to LSD1 and EZH2 in pancreatic cancer. Last author DOI 10.1007/s13277-016-5380-8↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bingqing Hui · 3 shared papers, 2017–2019 · strength 0.26
  2. Yan Zhou · 2 shared papers, 2017–2019 · strength 0.17
  3. Jianwei Lu · 1 shared paper, 2019 · strength 0.10
  4. Zhonghua Ma · 1 shared paper, 2017 · strength 0.07
  5. Yifan Lian · 1 shared paper, 2016 · strength 0.06
  6. Juan Wang · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.